Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double-blind, placebo-controlled trial. (Q51348266)
Jump to navigation
Jump to search
scientific article published on 25 January 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double-blind, placebo-controlled trial. |
scientific article published on 25 January 2013 |
Statements
1 reference
Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double-blind, placebo-controlled trial. (English)
1 reference
K Kaku
1 reference
S Inoue
1 reference
O Matsuoka
1 reference
A Kiyosue
1 reference
H Azuma
1 reference
N Hayashi
1 reference
T Tokudome
1 reference
A M Langkilde
1 reference
S Parikh
1 reference
25 January 2013
1 reference
15
1 reference
432-440
1 reference
5
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference